Todorova, Krassimira and Metodiev, Metodi V and Metodieva, Gergana and Mincheff, Milcho and Fernández, Nelson and Hayrabedyan, Soren (2017) Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer. Hormones and Cancer, 8 (1). pp. 28-48. DOI https://doi.org/10.1007/s12672-016-0279-9
Todorova, Krassimira and Metodiev, Metodi V and Metodieva, Gergana and Mincheff, Milcho and Fernández, Nelson and Hayrabedyan, Soren (2017) Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer. Hormones and Cancer, 8 (1). pp. 28-48. DOI https://doi.org/10.1007/s12672-016-0279-9
Todorova, Krassimira and Metodiev, Metodi V and Metodieva, Gergana and Mincheff, Milcho and Fernández, Nelson and Hayrabedyan, Soren (2017) Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer. Hormones and Cancer, 8 (1). pp. 28-48. DOI https://doi.org/10.1007/s12672-016-0279-9
Abstract
Cancer progression is driven by genome instability incurred rearrangements such as transmembrane protease, serine 2 (TMPRSS2)/v-ets erythroblastosis virus E26 oncogene (ERG) that could possibly turn some of the tumor suppressor micro-RNAs into pro-oncogenic ones. Previously, we found dualistic miR-204 effects, acting either as a tumor suppressor or as an oncomiR in ERG fusion-dependent manner. Here, we provided further evidence for an important role of miR-204 for TMPRSS2/ERG and androgen receptor (AR) signaling modulation and fine tuning that prevents TMPRSS2/ERG overexpression in prostate cancer. Based on proximity-based ligation assay, we designed a novel method for detection of TMPRSS2/ERG protein products. We found that miR-204 is TMPRSS2/ERG oncofusion negative regulator, and this was mediated by DNA methylation of TMPRSS2 promoter. Transcriptional factors runt-related transcription factor 2 (RUNX2) and ETS proto-oncogene 1 (ETS1) were positive regulators of TMPRSS2/ERG expression and promoter hypo-methylation. Clustering of patients’ sera for fusion protein, transcript expression, and wild-type ERG transcript isoforms, demonstrated not all patients harboring fusion transcripts had fusion protein products, and only few fusion positive ones exhibited increased wild-type ERG transcripts. miR-204 upregulated AR through direct promoter hypo-methylation, potentiated by the presence of ERG fusion and RUNX2 and ETS1. Proteomics studies provided evidence that miR-204 has dualistic role in AR cancer-related reprogramming, promoting prostate cancer-related androgen-responsive genes and AR target genes, as well as AR co-regulatory molecules. miR-204 methylation regulation was supported by changes in molecules responsible for chromatin remodeling, DNA methylation, and its regulation. In summary, miR-204 is a mild regulator of the AR function during the phase of preserved AR sensitivity as the latter one is required for ERG-fusion translocation.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Cell Line, Tumor; Humans; Prostatic Neoplasms; Serine Endopeptidases; Oncogene Proteins, Fusion; Receptors, Androgen; MicroRNAs; Proteomics; Signal Transduction; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Rearrangement; Male; Core Binding Factor Alpha 1 Subunit; Proto-Oncogene Protein c-ets-1; Promoter Regions, Genetic; Transcriptional Regulator ERG; Proto-Oncogene Mas |
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
Divisions: | Faculty of Science and Health Faculty of Science and Health > Life Sciences, School of |
SWORD Depositor: | Unnamed user with email elements@essex.ac.uk |
Depositing User: | Unnamed user with email elements@essex.ac.uk |
Date Deposited: | 28 Feb 2017 10:53 |
Last Modified: | 30 Oct 2024 20:26 |
URI: | http://repository.essex.ac.uk/id/eprint/19017 |